Financials

  • Market Capitalization 2.24 M
  • Employee 17
  • Founded 2015
  • CEO N/A
  • Website www.moleculin.com
  • Headquarter Delaware, United States
  • FIGI BBG00B9T47L9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4912
GOVX
GeoVax Labs, Inc. - Common Stock
0.72 USD+2.86%-24.21%-42.40%-50.34%5.31 M USD
4916
NCNA
NuCana plc - American Depositary Shares
1.31 USD+3.97%+0.77%-14.38%-39.07%5.45 M USD
4918
MLEC
Moolec Science SA - Ordinary Shares
7.10 USD-1.66%+3.20%-4.05%+118.46%5.16 M USD
4919
APVO
Aptevo Therapeutics Inc. - Common Stock
4.13 USD+3.77%-5.28%-8.22%-38.81%5.15 M USD

Frequently asked questions about Moleculin Biotech, Inc. - Common Stock

What is the Moleculin Biotech, Inc. - Common Stock stock price today?

The current price of Moleculin Biotech, Inc. - Common Stock (MBRX) is 0.42. Over the past 24 hours, the stock has changed by -58.82%. Follow the MBRX chart for real-time price dynamics.

What is the stock ticker of Moleculin Biotech, Inc. - Common Stock?

Moleculin Biotech, Inc. - Common Stock trades under the ticker MBRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Moleculin Biotech, Inc. - Common Stock stock going up?

MBRX has changed by -80.00% over the last week, -83.78% over the last month, and -86.67% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Moleculin Biotech, Inc. - Common Stock?

Moleculin Biotech, Inc. - Common Stock currently has a market capitalization of 2.24 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Moleculin Biotech, Inc. - Common Stock earnings last quarter?

Last quarter, Moleculin Biotech, Inc. - Common Stock reported earnings of -3.54 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Moleculin Biotech, Inc. - Common Stock revenue for the last quarter?

Moleculin Biotech, Inc. - Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Moleculin Biotech, Inc. - Common Stock net income for the last quarter?

Moleculin Biotech, Inc. - Common Stock reported net income of -12.85 M for the last quarter. The previous quarter showed 15.55 M, which means net income changed by -182.59%.

How many employees does Moleculin Biotech, Inc. - Common Stock have?

As of the latest available data, Moleculin Biotech, Inc. - Common Stock has 17 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Moleculin Biotech, Inc. - Common Stock stock?

You can buy Moleculin Biotech, Inc. - Common Stock (MBRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Moleculin Biotech, Inc. - Common Stock stock?

Investing in Moleculin Biotech, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MBRX chart and related analysis on metatrader.com as part of your research.

News